APA

McCormack S., Ramjee G., Kamali A., Rees H., Crook A. M., Gafos M., Jentsch U., Pool R., Chisembele M., Kapiga S., Mutemwa R., Vallely A., Palanee T., Sookrajh Y., Lacey C. J., Darbyshire J., Grosskurth H., Profy A., Nunn A., Hayes R. & Weber J. (20101028). PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. : Lancet (London, England).

Chicago

McCormack Sheena, Ramjee Gita, Kamali Anatoli, Rees Helen, Crook Angela M, Gafos Mitzy, Jentsch Ute, Pool Robert, Chisembele Maureen, Kapiga Saidi, Mutemwa Richard, Vallely Andrew, Palanee Thesla, Sookrajh Yuki, Lacey Charles J, Darbyshire Janet, Grosskurth Heiner, Profy Albert, Nunn Andrew, Hayes Richard and Weber Jonathan. 20101028. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. : Lancet (London, England).

Harvard

McCormack S., Ramjee G., Kamali A., Rees H., Crook A. M., Gafos M., Jentsch U., Pool R., Chisembele M., Kapiga S., Mutemwa R., Vallely A., Palanee T., Sookrajh Y., Lacey C. J., Darbyshire J., Grosskurth H., Profy A., Nunn A., Hayes R. and Weber J. (20101028). PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. : Lancet (London, England).

MLA

McCormack Sheena, Ramjee Gita, Kamali Anatoli, Rees Helen, Crook Angela M, Gafos Mitzy, Jentsch Ute, Pool Robert, Chisembele Maureen, Kapiga Saidi, Mutemwa Richard, Vallely Andrew, Palanee Thesla, Sookrajh Yuki, Lacey Charles J, Darbyshire Janet, Grosskurth Heiner, Profy Albert, Nunn Andrew, Hayes Richard and Weber Jonathan. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. : Lancet (London, England). 20101028.